InflaRx NV (IFRX)
1.72
+0.01
(+0.58%)
USD |
NASDAQ |
Oct 02, 16:00
1.725
0.00 (0.00%)
After-Hours: 20:00
InflaRx Market Cap : 253.47M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 253.47M |
| October 01, 2026 | 252.00M |
| September 30, 2026 | 265.26M |
| September 29, 2026 | 272.63M |
| September 28, 2026 | 268.21M |
| September 25, 2026 | 278.53M |
| September 24, 2026 | 284.42M |
| September 23, 2026 | 288.84M |
| September 22, 2026 | 306.53M |
| September 21, 2026 | 312.42M |
| September 18, 2026 | 308.00M |
| September 17, 2026 | 303.58M |
| September 16, 2026 | 300.63M |
| September 15, 2026 | 297.68M |
| September 14, 2026 | 312.42M |
| September 11, 2026 | 308.00M |
| September 10, 2026 | 302.10M |
| September 09, 2026 | 308.00M |
| September 08, 2026 | 319.79M |
| September 04, 2026 | 327.16M |
| September 03, 2026 | 328.63M |
| September 02, 2026 | 337.47M |
| September 01, 2026 | 318.32M |
| August 31, 2026 | 313.89M |
| August 28, 2026 | 328.63M |
| Date | Value |
|---|---|
| August 27, 2026 | 334.53M |
| August 26, 2026 | 356.63M |
| August 25, 2026 | 362.53M |
| August 24, 2026 | 302.10M |
| August 21, 2026 | 309.47M |
| August 20, 2026 | 297.68M |
| August 19, 2026 | 312.42M |
| August 18, 2026 | 321.26M |
| August 17, 2026 | 305.05M |
| August 14, 2026 | 300.63M |
| August 13, 2026 | 296.21M |
| August 12, 2026 | 296.21M |
| August 11, 2026 | 294.74M |
| August 10, 2026 | 288.84M |
| August 07, 2026 | 271.16M |
| August 06, 2026 | 253.47M |
| August 05, 2026 | 260.84M |
| August 04, 2026 | 262.32M |
| August 03, 2026 | 126.51M |
| July 31, 2026 | 122.90M |
| July 30, 2026 | 124.34M |
| July 29, 2026 | 119.28M |
| July 28, 2026 | 122.18M |
| July 27, 2026 | 122.90M |
| July 24, 2026 | 125.79M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| MediGene AG | 1.474M |
| BioNTech SE | 24.34B |
| Immatics NV | 1.037B |
| Arrowhead Pharmaceuticals, Inc. | 9.059B |
| Oncolytics Biotech, Inc. | 78.65M |
Market Cap Related Metrics
| PS Ratio | 1930.26 |
| Price to Book Value | 1.517 |
| Price | 1.72 |
| Earnings Yield | -37.70% |